Sonic Healthcare Ltd
SHL: XASX (AUS)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
A$91.00 | Wmnjtk | Hkffcts |
Sonic Healthcare: Downgrade to Near-Term Earnings but Long-Term Intact
Narrow-moat Sonic’s top line continues to grow at a steady clip, with organic revenue up 6% so far in the second half of fiscal 2024, following 6% growth in the first half. Our fiscal 2024 revenue forecast of AUD 8.9 billion is broadly unchanged and in line with company guidance.